Healthcare | December 08, 2021
Cadila Pharma launches ayurvedic energy tonic Healtherbs
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
_256_384.jpg)
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
The event was organized jointly by Oncology Forum and Fortis Cancer Institute, Delhi NCR
Lupin had earlier received the U.S. FDA acceptance of the Biologics License Application (BLA) for Its proposed biosimilar
This further adds to Biocon’s portfolio of vertically integrated complex drug products
Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
Subscribe To Our Newsletter & Stay Updated
